TVTX R&D Expense Growth
Travere Therapeutics Inc · R&D Expense Growth
TVTX R&D Expense Growth
Latest reported-27.13%period ending
TVTX FY R&D Growth (YoY) (0.00% → -27.13%)
Latest values, visible window
High-resolution chart · PNG
TVTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -27.1276% | |
| 15.3929% | |
| 7.767% | |
| 13.0116% | |
| 52.6557% | |
| -6.5194% | |
| 13.9031% | |
| 58.3218% | |
| 10.3242% | |
| 40.5089% | |
| 5.5043% | |
| 574.6917% | |
| 969.2811% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |